HORIZON-EIC-2023-ACCELERATOROPEN-01
HORIZON-EIC-2023-ACCELERATOROPEN-01
Programme: Horizon Europe
126 projects · €299,709,635 total EU contribution (project-level) · 141 participating organizations · 23 countries with participants
Total EU funding
Sum of EC max contribution fields for distinct projects in this topic.
€299,709,635
Countries active
Participant organizations by country (headquarters in CORDIS).
- Netherlands (23)
- France (20)
- Germany (15)
- SE (11)
- Spain (9)
- IL (8)
- IE (7)
- PT (7)
- DK (6)
- BG (5)
- FI (5)
- Italy (5)
- BE (4)
- EE (4)
- NO (4)
- AT (1)
- CY (1)
- HU (1)
- LT (1)
- LV (1)
- PL (1)
- SK (1)
- UA (1)
Open calls
From the EU Funding & Tenders Portal, linked to this topic code when it matches the call identifier. Sync via yarn etl:funding.
No open or forthcoming calls linked to this topic in the database yet.
Top organizations
By number of distinct projects in this topic.
- ACORAI AB1 projects · SE
- ALIAS1 projects · ES
- ANGIOLUTIONS GMBH1 projects · DE
- APTATARGETS SL1 projects · ES
- AURORA1 projects · FR
- ACWA ROBOTICS1 projects · FR
- AVELIOS MEDICAL GMBH1 projects · DE
- BAC3GEL, LDA.1 projects · PT
- BASEMARK GMBH1 projects · DE
- BASEMARK OY1 projects · FI
- BEIT SP Z.O.O.1 projects · PL
- BETAGLUE THERAPEUTICS SPA1 projects · IT
Projects
Page 10 of 13
| Project | Programme | EU contribution | Total cost | |
|---|---|---|---|---|
FIRST-IN-CLASS MYC INHIBITOR: THE MAKING OF A BREAKTHROUGH CANCER THERAPY MYCureX · 101144681 | HORIZON | €2,494,504 | €3,563,578 | Details |
RESPILIQ - enteral CO2 absorption for the therapy of hypercapnic lung failure RESPILIQ · 101166201 | HORIZON | €2,499,999 | €3,603,639 | Details |
Development of a cell immunotherapy targeting non-conventional tumor antigens in ovarian cancer OVACell · 101145335 | HORIZON | €2,499,999 | €3,650,068 | Details |
Innovative patented dry fermentation technology for cost-effective and highly nutritious production of hybrid mycelium-plant meat analogues MEATLOW · 101165614 | HORIZON | €2,441,250 | €3,487,500 | Details |
Silk fibroin tissue grafting for peripheral nerve repair KLISBio · 101161926 | HORIZON | €2,495,500 | €3,565,000 | Details |
Production of High-quality Fatty Acids Feedstock for use in SAF Production GAFT · 190104418 | HORIZON | €2,499,999 | €0 | Details |
a Quasi Coherent Receiver Optical Sub-Assembly technology for improved access networks qc-rosa · 190184742 | HORIZON | €2,498,267 | €3,568,953 | Details |
Worlds first sulfuric acid-free kraft lignin recovery system LignEasy · 190123865 | HORIZON | €2,031,050 | €2,901,500 | Details |
Plasma-based point-source CCU technology to recycle CO2 into added value chemicals to decarbonize hard-to-abate industries D-CRBN · 101161563 | HORIZON | €2,499,999 | €3,607,500 | Details |
The first non-surgical repair for Pelvic Organ Prolapse apyx · 190143220 | HORIZON | €2,500,000 | €5,067,216 | Details |